Overview
Syndactyly-telecanthus-anogenital and renal malformations syndrome (also known as STAR syndrome) is an extremely rare congenital malformation syndrome characterized by a distinctive combination of anomalies affecting multiple body systems. The name is an acronym derived from its cardinal features: Syndactyly (fusion of fingers or toes), Telecanthus (widely spaced inner corners of the eyes), Anogenital malformations, and Renal (kidney) malformations. Affected individuals typically present at birth with toe syndactyly (particularly cutaneous syndactyly of the second and third toes), facial dysmorphism including telecanthus, and various urogenital anomalies such as anteriorly placed anus, vaginal or uterine anomalies in females, and renal malformations including renal agenesis or ectopic kidneys. Additional features may include shawl scrotum or penoscrotal transposition in males. This syndrome has been reported in only a very small number of families in the medical literature, making it one of the rarest multiple congenital anomaly syndromes. The condition appears to follow an X-linked dominant inheritance pattern, and it has been associated with mutations in the FAM58A gene (also known as CCNQ), which encodes a cyclin family protein involved in cell cycle regulation. Because the condition is present from birth, diagnosis is typically made in the neonatal period based on the constellation of physical findings. Management is supportive and symptom-based, potentially involving surgical correction of syndactyly, monitoring and management of renal anomalies, and surgical intervention for anogenital malformations as needed. There is currently no specific or curative treatment for this syndrome. Long-term follow-up by a multidisciplinary team including geneticists, nephrologists, urologists, and orthopedic surgeons is recommended.
Also known as:
Clinical phenotype terms— hover any for plain English:
X-linked dominant
Carried on the X chromosome; a single copy can cause the condition
Neonatal
Begins at or shortly after birth (first 4 weeks)
FDA & Trial Timeline
2 eventsYonsei University — PHASE4
Centre intégré universitaire de santé et de services sociaux de la Mauricie-et-du-Centre-du-Québec — NA
Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
Treatments
No FDA-approved treatments are currently listed for Syndactyly-telecanthus-anogenital and renal malformations syndrome.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Syndactyly-telecanthus-anogenital and renal malformations syndrome at this time.
New trials open frequently. Follow this disease to get notified.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Syndactyly-telecanthus-anogenital and renal malformations syndrome.
Community
No community posts yet. Be the first to share your experience with Syndactyly-telecanthus-anogenital and renal malformations syndrome.
Start the conversation →Latest news about Syndactyly-telecanthus-anogenital and renal malformations syndrome
Disease timeline:
New recruiting trial: Stellate Ganglion Block for Long COVID Symptoms: A Randomized Controlled Trial
A new clinical trial is recruiting patients for Syndactyly-telecanthus-anogenital and renal malformations syndrome
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Syndactyly-telecanthus-anogenital and renal malformations syndrome
What is Syndactyly-telecanthus-anogenital and renal malformations syndrome?
Syndactyly-telecanthus-anogenital and renal malformations syndrome (also known as STAR syndrome) is an extremely rare congenital malformation syndrome characterized by a distinctive combination of anomalies affecting multiple body systems. The name is an acronym derived from its cardinal features: Syndactyly (fusion of fingers or toes), Telecanthus (widely spaced inner corners of the eyes), Anogenital malformations, and Renal (kidney) malformations. Affected individuals typically present at birth with toe syndactyly (particularly cutaneous syndactyly of the second and third toes), facial dysmo
How is Syndactyly-telecanthus-anogenital and renal malformations syndrome inherited?
Syndactyly-telecanthus-anogenital and renal malformations syndrome follows a x-linked dominant inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does Syndactyly-telecanthus-anogenital and renal malformations syndrome typically begin?
Typical onset of Syndactyly-telecanthus-anogenital and renal malformations syndrome is neonatal. Age of onset can vary across affected individuals.
Which specialists treat Syndactyly-telecanthus-anogenital and renal malformations syndrome?
2 specialists and care centers treating Syndactyly-telecanthus-anogenital and renal malformations syndrome are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.